BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹220 Cr | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr |
What is the latest Total Current Liabilities ratio of BAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹220 Cr |
| Mar2024 | ₹203 Cr |
| Mar2023 | ₹209 Cr |
| Mar2022 | ₹166 Cr |
| Mar2021 | ₹153 Cr |
How is Total Current Liabilities of BAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹220 Cr | 8.10 | |
| Mar2024 | ₹203 Cr | -3.00 | |
| Mar2023 | ₹209 Cr | 26.38 | |
| Mar2022 | ₹166 Cr | 8.60 | |
| Mar2021 | ₹153 Cr | - | |
Compare Total Current Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹115.4 Cr | -2.1% | -4.9% | -40% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.1% |
-4.9% |
-40% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses